PAPILLOMA VIRAL INFECTION IN PREGNANT WOMEN: WAYS TO SOLVE THE PROBLEM

Abstract

Peculiarities of the course of the papilloma viral infection in pregnancy are studied insufficiently. There is no generally accepted practice of patient maintenance. The aim of the study is to study possibilities of pharmaceutical correction of the papilloma viral infection (PVI) affected pregnant women. Various types of human papilloma virus are identified in 137 patients by polymerase chain reaction method. The immune system correction and therapy of sexually transmitted diseases was administered to 33 women. 31 women didn’t receive the immune system correction of therapy of sexually transmitted diseases. Spiramycyin, natamycyin, bifidumbacterin, tergynan, inferferon alpha2b + taurin were used for therapy. In addition to clinical and bacteriological study methods extended uterine colposcopy and cytologic methods of cervical smear were used. The obtained results allowed drawing a conclusion that the sexually transmitted diseases drug therapy and the immune system correction, improving the colposcopic pattern and quality of cytologic smears optimizing the course of pregnancy; the sexually transmitted disease therapy is less effective than simultaneous sexually transmitted disease therapy and immune system correction.